QINGSONG HEALTH (02661): The stable pricing period has ended, there are no stable pricing actions, and the oversubscription rights have expired.

QINGSONG HEALTH (02661) announced that the stabilisation period for the global offering ended on January 17, 2026 (Saturday) (i.e. the 30th day after the application deadline for the Hong Kong public offering). As there was no oversubscription in the international offering, the sponsor and overall coordinator (on behalf of themselves and the international underwriters) did not exercise the oversubscription rights. No stabilisation activities were carried out by the stabilisation manager or any person acting on their behalf during the stabilisation period. The oversubscription rights expired on January 17, 2026 (Saturday) (i.e. the 30th day after the application deadline for the Hong Kong public offering). Therefore, no shares have been or will be issued under the oversubscription rights.